Jing Marantz
Technik-/Wissenschafts-/F&E-Leiter bei SCHOLAR ROCK HOLDING CORPORATION
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Jing Marantz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARCTURUS THERAPEUTICS HOLDINGS INC. | Direktor/Vorstandsmitglied | 07.12.2021 | - |
Independent Dir/Board Member | 07.12.2021 | - | |
SCHOLAR ROCK HOLDING CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 09.11.2022 | - |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jing Marantz
Ehemalige bekannte Positionen von Jing Marantz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KRYSTAL BIOTECH, INC. | Direktor/Vorstandsmitglied | 04.01.2021 | 18.01.2022 |
Independent Dir/Board Member | 04.01.2021 | 18.01.2022 | |
Corporate Officer/Principal | 18.01.2022 | 01.08.2022 | |
ACCELERON PHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2020 | 01.11.2021 |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 20.06.2018 | 01.09.2020 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2016 | 01.06.2018 |
ARIAD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2012 | - |
Ausbildung von Jing Marantz
Tongji Medical College of Huazhong University of Sci & Tech | Doctorate Degree |
Medical University of South Carolina | Doctorate Degree |
University of California, Berkeley | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 12 |
China | 2 |
Operativ
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 10 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
KRYSTAL BIOTECH, INC. | Health Technology |
ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
Private Unternehmen | 5 |
---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Jing Marantz
- Erfahrung